<DOC>
	<DOC>NCT00638079</DOC>
	<brief_summary>To evaluate the effect of food on the rate and extent of absorption of megestrol acetate 625 mg/5 mL , and determine the safety and tolerability of megestrol acetate 625 mg/5 mL in healthy individuals.</brief_summary>
	<brief_title>Evaluating the Effect of Food on Absorption of Megace ES</brief_title>
	<detailed_description />
	<mesh_term>Megestrol</mesh_term>
	<mesh_term>Megestrol Acetate</mesh_term>
	<criteria>Body weight ranging from 60100 kg (132220 lbs) and body mass index ≥18 and ≤32 Healthy History of or any current medical conditions that could interfere with drug consumption, absorption, distribution, metabolism (eg. CYP450 inducers or inhibitors), or excretion of study drug History of or any current medical conditions that could affect subject safety History of frequent nausea or emesis, regardless of etiology Participation in a clinical drug study during the 30 days preceding the initial dose Significant illness during the 4 weeks preceding study entry Use of any medication, including vitamins/herbal/mineral supplements, during the 7 days preceding the initial dose Refusal or inability to abstain from food 10 hours proceeding and 4 hours following study drug administration, to consume the FDA high fat meal as directed, and to abstain from caffeine or xanthinecontaining beverages entirely during each confinement Any history of or current drug or alcohol abuse Prior alcohol intake exceeding the equivalent of 14 units/week (12 oz beer = 4 oz wine = 1.5 oz shot = 1 unit) on average, or consumption of any alcoholic beverages within 48 hours of study drug administration History of smoking&gt;25 cigarettes/day within 45 days of study drug administration Blood or blood products donated within 30 days prior to study drug administration, or anytime during the study, except as required by this protocol Positive results of urine drug screen, blood alcohol by a Breathalyzer test, hepatitis B surface antigen, hepatitis B surface antibody (unless immunized), or antiHCV</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Food Effect</keyword>
	<keyword>Bioavailability</keyword>
	<keyword>Megace ES</keyword>
</DOC>